https://www.cochrane.org/ru/evidence/CD009268_haloperidol-versus-first-generation-low-potency-antipsychotic-drugs-schizophrenia
Haloperidol versus first-generation low-potency antipsychotic drugs for schizophrenia | Cochrane
first generationlow potencyantipsychotic drugshaloperidolversus
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1086673/full
Frontiers | TLQP-21 is a low potency partial C3aR activator on human primary macrophages
TLQP-21 is a 21-amino acid neuropeptide derived from the VGF precursor protein. TLQP-21 is expressed in the nervous system and neuroendocrine glands, and dem...
https://pmc.ncbi.nlm.nih.gov/articles/PMC10460651/
The Potency of Platelet-Rich Plasma for Chronic Low Back Pain: A Systematic Review and...
Low back pain is one of the leading causes of disability in the world. Regenerative medicine can be one of the novel treatment breakthroughs in patients with...